Ohio State hematologist Dr. Kerry Rogers says chemotherapy and newer targeted drugs both work well, and the right choice depends on the patient.
|Videos|June 2, 2016
Our Trip to the Grand Canyon to Raise Money for Cancer Research
Author(s)Marty Murphy
Our director of patient education, Marty Murphy, discusses his trip for the Moving Mountains for Multiple Myeloma campaign with WRAL.
Advertisement
Our director of patient education, Marty Murphy, discusses his recent trip to the Grand Canyon as part of the Moving Mountains for Multiple Myeloma campaign, which raised money for cancer research.
Advertisement
Related to this article
Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.
A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.
A woman with stage 4 pancreatic cancer shares how a once-daily RAS inhibitor changed her energy, routine and time with family.
Brad Dugai and Russ Reed discuss symptom relief, skin-related side effects and challenges accessing Rasonque, a treatment for pancreatic cancer.
A nurse practitioner discusses how an app provides information on cancer treatments, potential side effects and preparing for medical appointments.
Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains what it means for patients.
A physician emphasized how emotional support, reliable health information and caregiver involvement can encourage men to take a more proactive approach to prostate cancer screening and care.
Advertisement
Advertisement
Trending on CURE
1
Tattoos and Lymphoma Risk: A Breast Cancer Survivor's Questions
2
Medicare Part D 2027: What a $2,400 Cap Means for Cancer Drugs
3
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
4
Anktiva Plus BCG Meets Main Goal in BCG-Naive Bladder Cancer Trial
5